Want to see IN:JAGSNPHARM full AI Analyst Report?
Summary of all the Indicators
Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Moving Averages Convergence Divergence (MACD) indicator is 3.12, suggesting Jagsonpal Pharmaceuticals Ltd. is a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 20-Day exponential moving average is 233.69, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Buy.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-Day exponential moving average is 227.54, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Buy.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Pivot Points
Classic
229.85
233.50
237.55
241.20
245.25
248.90
252.95
Fibonacci
233.50
236.44
238.26
241.20
244.14
245.96
248.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Moving Averages
MA5
238.70Buy
239.06Buy
MA10
234.37Buy
236.30Buy
MA20
234.04Buy
233.69Buy
MA50
229.72Buy
227.54Buy
MA100
216.32Buy
219.16Buy
MA200
202.47Buy
212.58Buy
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 10-Day exponential moving average is 236.30, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Buy.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-Day exponential moving average is 219.16, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Buy.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹193.5 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-day simple moving average is 229.72, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹193.5 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-day simple moving average is 216.32, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹193.5 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 200-day simple moving average is 202.47, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Technical Indicators
RSI (14)
62.88
Neutral
STOCH (9,6)
76.86
Neutral
STOCHRSI (14)
76.86
Neutral
MACD (12,26)
3.12
Sell
ADX (14)
32.71
Neutral
Williams %R
-18.22
Sell
CCI (14)
129.20
Sell
ATR (14)
8.28
-
Ultimate Oscillator
39.62
Neutral
ROC
2.06
Buy
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Relative Strength Index (RSI) is 62.88, creating a Neutral signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Trend Strength Indicator (ADX) is 32.71, creating a Neutral signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Commodity Channel Index (CCI) is 129.20, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Price Rate of Change (ROC) is 2.06, creating a Buy signal.
FAQ
Is JAGSNPHARM a Buy, Hold, or Sell?
Based on JAGSNPHARM’s technical indicators, JAGSNPHARM is a Buy.
What is JAGSNPHARM’s RSI (14)?
JAGSNPHARM’s RSI (14) is 62.88, which suggests JAGSNPHARM is a Neutral.
What is JAGSNPHARM’s MACD?
JAGSNPHARM’s MACD is 3.12, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s 5-day moving average?
JAGSNPHARM’s 5-day moving average is 238.70, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s 20-day moving average?
JAGSNPHARM 20-day moving average is 234.04, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s 50-day moving average?
JAGSNPHARM’s 50-day moving average is 229.72, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s 200-day moving average?
JAGSNPHARM’s 200-day moving average is 202.47, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s Williams % R (14)?
JAGSNPHARM’s Williams % R (14) is -18.22, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s CCI (14)?
JAGSNPHARM’s CCI (14) is 129.20, which suggests JAGSNPHARM is a Sell.
What is the share price of Jagsonpal Pharmaceuticals Ltd.?